(3-Methoxy-2-methylpropyl)benzene
Common Name: |
(3-Methoxy-2-methylpropyl)benzene |
IUPAC Name: |
(3-methoxy-2-methylpropyl)benzene |
Molecular Formula: |
C11H22O |
SMILES: |
CC(CC1=CC=CC=C1)COC |
Inchi: |
1S/C11H16O/c1-10(9-12-2)8-11-6-4-3-5-7-11/h3-7,10H,8-9H2,1-2H3 |
Inchi Key: |
YRELUSXNOZNOQI-UHFFFAOYSA-N |
Cas No: |
120811-92-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
170.29 |
Mass (g/mol) |
164.12 |
Molar Refractivity |
54.08 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
225.64 |
Vapor Pressure (mmHg@25.00 °C) |
0.128 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
2.512 |
iLOGP |
2.73 |
XLOGP3 |
3.31 |
WLOGP |
2.97 |
MLOGP |
2.74 |
ESOL Log S |
-2.85 |
ESOL Solubility (mg/ml) |
0.241 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.41 |
Ali Solubility (mg/ml) |
0.07 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.34 |
Silicos-IT Solubility (mg/ml) |
0.78 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.99 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.898 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.824 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |